Pulmonary Hypertension

Pulmonary hypertension is a condition in which blood pressure is abnormally elevated specifically in the pulmonary arteries, the blood vessels that carry blood from the right side of the heart to the lungs to pick up oxygen. This is different from the systemic blood pressure measured with a standard arm cuff, which reflects pressure in the arteries supplying the rest of the body.

No, and this distinction matters a great deal. Pulmonary hypertension (PH) is a broad category that includes several different underlying causes. Pulmonary arterial hypertension (PAH) is one specific, less common category within that broader group, involving narrowing or stiffening of the small pulmonary arteries themselves. PAH has its own distinct, specialized medications that are not appropriate treatment for most other forms of pulmonary hypertension. Using the terms interchangeably can lead to confusion about diagnosis and treatment.

Pulmonary hypertension has several different underlying categories of cause. It is frequently related to left-heart conditions such as heart failure or valve disease, to chronic lung disease such as COPD or interstitial lung disease, to chronic low blood oxygen, or to blood clots in the lung arteries that don't fully resolve. A smaller, distinct category, pulmonary arterial hypertension, involves the small pulmonary arteries directly. Identifying which category applies is central to figuring out the right treatment approach.

The most common symptom is shortness of breath, particularly with exertion, along with fatigue, swelling in the legs or ankles, chest discomfort, and palpitations. In more advanced cases, lightheadedness or fainting with activity can occur. These symptoms overlap with many other conditions, which is part of why pulmonary hypertension can be under-recognized.

Evaluation typically starts with a history and physical exam, followed by echocardiography, which can estimate pulmonary artery pressure and suggest that pulmonary hypertension may be present. Right-heart catheterization, a more invasive procedure that directly measures pressures inside the heart and pulmonary arteries, is the reference-standard test used to confirm the diagnosis. Pulmonary function testing and imaging, such as CT scanning or a ventilation/perfusion (V/Q) scan, are often used to help identify an underlying cause, such as chronic lung disease or blood clots.

No. Echocardiography is usually the first screening test and is genuinely useful for raising suspicion of elevated pulmonary pressures, but it is an estimation tool rather than a definitive diagnostic test. A formal diagnosis of pulmonary hypertension requires right-heart catheterization, which measures pressures directly rather than estimating them indirectly.

Right-heart catheterization is a procedure in which a thin catheter is guided into the right side of the heart and pulmonary arteries to measure pressures directly. Because echocardiography only estimates pulmonary pressures, right-heart catheterization is considered the reference-standard confirmatory test for pulmonary hypertension and also helps clarify its severity and, in some cases, its underlying category.

Chronic lung diseases such as COPD and interstitial lung disease are common underlying contributors to pulmonary hypertension, often related to long-standing low blood oxygen levels and changes in the lung's blood vessels. When pulmonary hypertension develops in this setting, managing the underlying lung disease is typically a central part of the treatment approach, rather than using PAH-specific therapies.

Untreated sleep apnea and chronic low oxygen during sleep can contribute to, or worsen, pulmonary hypertension in some patients, though it is best understood as a contributing factor rather than a universal or sole cause. Evaluating and treating sleep-disordered breathing can be a relevant part of the overall management plan when it's identified as a contributor.

It depends on the underlying cause. Some forms, such as pulmonary hypertension related to blood clots, may be substantially improved or resolved with targeted treatment. Others, including those related to chronic lung disease, left-heart disease, or PAH, are generally managed as ongoing conditions rather than cured outright, though treatment can meaningfully improve symptoms and, for some patients, slow progression. There is no single answer that applies to everyone, which is part of why identifying the specific cause matters so much.

It can be, particularly if it goes unrecognized and untreated, since sustained elevated pressure can strain the right side of the heart over time. The seriousness and expected course vary considerably depending on the underlying cause and how early it's identified, which is why unexplained or progressive shortness of breath deserves timely evaluation rather than being dismissed.

Management typically involves a pulmonologist and often a cardiologist, since the condition sits at the intersection of lung and heart health. For certain categories, particularly PAH or chronic thromboembolic disease, referral to a specialist or center with specific experience in that category is often appropriate, since treatment approaches are quite specialized.